Paradigm Shift in the Management of Acute Myeloid Leukemia—Approved Options in 2023

por Premnath, Naveen, Madanat, Yazan F.
Publicado 2023

Novel Investigational Agents and Pathways That May Influence the Future Management of Acute Myeloid Leukemia

por Premnath, Naveen, Madanat, Yazan F.
Publicado 2023

Molecular Drivers of Myelodysplastic Neoplasms (MDS)—Classification and Prognostic Relevance

por Hoff, Fieke W., Madanat, Yazan F.
Publicado 2023

Idelalisib therapy of indolent B-cell malignancies: chronic lymphocytic leukemia and small lymphocytic or follicular lymphomas

por Madanat, Yazan F, Smith, Mitchell R, Almasan, Alexandru, Hill, Brian T
Publicado 2016

Anti-Spike Antibody Responses in Allogeneic Stem Cell Transplant Recipients to Two Doses of COVID-19 mRNA Vaccination: A Retrospective, Single-Center Analysis

por Shahan, Jaime L., Collins, Robert H., Patel, Prapti, Madanat, Yazan F., Vusirikala, Madhuri
Publicado 2023

Presence but not number of secondary type mutations influences outcome in de novo AML without MDS‐associated or recurring cytogenetic abnormalities

por Weinberg, Olga K., Cantu, Miguel D., Gagan, Jeffrey, Madanat, Yazan F., Arber, Daniel A., Hasserjian, Robert P.
Publicado 2023

TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML

por Weinberg, Olga K., Siddon, Alexa, Madanat, Yazan F., Gagan, Jeffrey, Arber, Daniel A., Dal Cin, Paola, Narayanan, Damodaran, Ouseph, Madhu M., Kurzer, Jason H., Hasserjian, Robert P.
Publicado 2022

P536: A FIRST-IN-HUMAN PHASE 1 STUDY OF IO-202 (ANTI-LILRB4 MAB) IN ACUTE MYELOID LEUKEMIA (AML) WITH MONOCYTIC DIFFERENTIATION AND CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML) PATIENTS

por Dinardo, Courtney, Pollyea, Daniel, Aribi, Ahmed, Jonas, Brian, Jeyakumar, Deepa, Roboz, Gail, Liu, Hongtao, Dunavin, Neil, Blum, William, Zhang, Alec, Tabata, Yasuhiro, Valencia, Donna, Huang, Tao, Hong, Kyu, Xiang, Hong, Liao, Charlene, Woodard, Paul, Madanat, Yazan
Publicado 2023

COVID Vaccine Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Better Antibody Response in Patients with Myeloid Malignancies Than B-Cel...

por Goksu, Suleyman Y, Rolwes, John, Premnath, Naveen, Patel, Prapti, Ikpefan, Ruth, Kaur, Gurbakhash, Vusirikala, Madhuri, Bat, Taha, Chen, Weina, Ramakrishnan, Praveen, Kansagra, Ankit, Anderson, Larry D., Awan, Farrukh T., Collins, Robert H., Chung, Stephen, Madanat, Yazan F.
Publicado 2021

Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience

por Sannareddy, Aishwarya, Reves, Heather, Jaleta, Kefyalew, .Ramiahsankarasubramanian, Ramyakumari, Patel, Hetalkumari, Narasimhan, Madhusudhanan, Anderson, Larry D., Afrough, Aimaz, Chung, Stephen S., Collins, Robert H., Kaur, Gurbakhash, Kumar, Kiran A, Madanat, Yazan F., Vusirikala, Madhuri, Awan, Farrukh T., Muthukumar, Alagarraju, Ramakrishnan Geethakumari, Praveen
Publicado 2022

Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia

por Bahaj, Waled, Kewan, Tariq, Gurnari, Carmelo, Durmaz, Arda, Ponvilawan, Ben, Pandit, Ishani, Kubota, Yasuo, Ogbue, Olisaemeka D., Zawit, Misam, Madanat, Yazan, Bat, Taha, Balasubramanian, Suresh K., Awada, Hussein, Ahmed, Ramsha, Mori, Minako, Meggendorfer, Manja, Haferlach, Torsten, Visconte, Valeria, Maciejewski, Jaroslaw P.
Publicado 2023

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia

por Bahaj, Waled, Kewan, Tariq, Gurnari, Carmelo, Durmaz, Arda, Ponvilawan, Ben, Pandit, Ishani, Kubota, Yasuo, Ogbue, Olisaemeka D., Zawit, Misam, Madanat, Yazan, Bat, Taha, Balasubramanian, Suresh K., Awada, Hussein, Ahmed, Ramsha, Mori, Minako, Meggendorfer, Manja, Haferlach, Torsten, Visconte, Valeria, Maciejewski, Jaroslaw P.
Publicado 2023

P745: MULTI-CENTER PHASE IB TRIAL OF THE HISTONE DEACTYLASE INHIBITOR ENTINOSTAT + PEMBROLIZUMAB IN MYELODYSPLASTIC SYNDROME OR ACUTE MYELOID LEUKEMIA REFRACTORY TO HYPOMETHYLATING...

por Bewersdorf, Jan, M. Shallis, Rory, Sharon, Elad, Caldwell, Anne, Wei, Wei, Yacoub, Abdulraheem, Madanat, Yazan, Zeidner, Joshua, Altman, Jessica, Odenike, Olatoyosi, Yerrabothala, Swaroopa, Kovacsovics, Tibor, Podoltsev, Nikolai, Halene, Stephanie, Little, Richard, Pierkarz, Richard, Gore, Steven, Kon Kim, Tae, M. Zeidan, Amer
Publicado 2023

‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies

por Sannareddy, Aishwarya, Reves, Heather, Narasimhan, Madhusudhanan, Jaleta, Kefyalew, Anderson, Julia Marie, Patel, Hetalkumari, Anderson, Larry D., Afrough, Aimaz, Chung, Stephen, Collins, Robert H., Kaur, Gurbakhash, Kumar, Kiran A, Madanat, Yazan F., Vusirikala, Madhuri, Awan, Farrukh T, Muthukumar, Alagar R, Geethakumari, Praveen Ramakrishnan
Publicado 2023

SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation

por Hoff, Fieke W., Goksu, Suleyman Y., Premnath, Naveen, Patel, Prapti A., Ikpefan, Ruth, Kaur, Gurbakhash, Vusirikala, Madhuri, Bat, Taha, Chen, Weina, Geethakumari, Praveen Ramakrishnan, Anderson, Larry D., Awan, Farrukh T., Collins, Robert H., Weinberg, Olga K., Muthukumar, Alagarraju, Chung, Stephen S., Madanat, Yazan F.
Publicado 2023

P724: UPDATED SUBSTUDY RESULTS FOR IVOSIDENIB IN IDH1-MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME

por Dinardo, Courtney, Roboz, Gail, M. Watts, Justin, Madanat, Yazan, T Prince, Gabrielle, Baratam, Praneeth, de Botton, Stéphane, Stein, Anthony, M Foran, James, L Arellano, Martha, Sallman, David, M Marchione, Dylan, Bai, Xiaofei, A Patel, Prapti, M Kapsalis, Stephanie, Garcia-Manero, Guillermo, Fathi, Amir
Publicado 2023

S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AG...

por Platzbecker, Uwe, Santini, Valeria, Fenaux, Pierre, Sekeres, Mikkael, Savona, Michael Robert, Madanat, Yazan, Díez Campelo, María, Valcárcel, David, Illmer, Thomas, Jonášová, Anna, Belohlavkova, Petra, Sherman, Laurie, Berry, Tymara, Dougherty, Souria, Shah, Sheetal, Xia, Qi, Peng, Lixian, Sun, Libo, Wan, Ying, Huang, Fei, Ikin, Annat, Navada, Shyamala, Komrokji, Rami S., Zeidan, Amer M.
Publicado 2023

S164: DISEASE MODIFYING ACTIVITY OF IMETELSTAT IN PATIENTS WITH HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATIN...

por Santini, Valeria, Platzbecker, Uwe, Fenaux, Pierre, Sekeres, Mikkael, Savona, Michael Robert, Madanat, Yazan, Campelo, María Díez, Valcárcel, David, Illmer, Thomas, Jonášová, Anna, Belohlavkova, Petra, Sherman, Laurie, Berry, Tymara, Dougherty, Souria, Shah, Sheetal, Xia, Qi, Peng, Lixian, Sun, Libo, Wan, Ying, Huang, Fei, Ikin, Annat, Navada, Shyamala, Feller, Faye, Zeidan, Amer M., Komrokji, Rami S.
Publicado 2023

P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETING MUTANT TP53 AND/OR COMPLEX KARYOTYPE IN PATIENTS WITH UNTREATED ACUTE MYELOID LEUKEMIA (AML) ≥ AGE 60 YEARS: FINAL RESU...

por Mims, Alice, Huang, Ying, Eisenmann, Eric, Orwick, Shelley, Buelow, Daelynn, Swords, Ronan, Zeidner, Joshua, Foster, Matthew, L. Lin, Tara, Baer, Maria, Madanat, Yazan, Kovacsovics, Tibor, Redner, Robert, Al-Mansour, Zeina, Stefanos, Mona, Martycz, Molly, Druggan, Franchesca, Chen, Timothy, Yocum, Ashley, Borate, Uma, Druker, Brian, Burd, Amy, Levine, Ross, Baker, Sharyn, C. Byrd, John
Publicado 2023

Molecular patterns identify distinct subclasses of myeloid neoplasia

por Kewan, Tariq, Durmaz, Arda, Bahaj, Waled, Gurnari, Carmelo, Terkawi, Laila, Awada, Hussein, Ogbue, Olisaemeka D., Ahmed, Ramsha, Pagliuca, Simona, Awada, Hassan, Kutoba, Yasuo, Mori, Minako, Ponvilawan, Ben, Al-Share, Bayan, Patel, Bhumika J., Carraway, Hetty E., Scott, Jacob, Balasubramanian, Suresh K., Bat, Taha, Madanat, Yazan, Sekeres, Mikkael A., Haferlach, Torsten, Visconte, Valeria, Maciejewski, Jaroslaw P.
Publicado 2023